Synageva BioPharma Corp (NASDAQ:GEVA)

98.89
Delayed Data
As of May 01
 +6.93 / +7.54%
Today’s Change
60.19
Today|||52-Week Range
122.88
+6.57%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Baker Bros Advisors Lp
Buy1/07/20151,000,000$94.19$94.2M-4.93%
Baker Bros Advisors Lp
Buy1/07/20151,000,000$94.19$94.2M-4.93%
Williams Glen
Senior Vice President-Technical Operations
Sale4/08/201539,863$96.08$3.8M+2.57%
Quinn Anthony
Sale4/06/201529,503$93.76$2.8M+6.57%
Patel Sanj K
President & Chief Executive Officer
Sale12/17/201426,960$90.06$2.4M+2.97%
Boess Carsten
Chief Financial Officer & Senior Vice President
Sale10/30/201422,904$80.11$1.8M+23.52%
Goldberg Mark Alan
Sale6/11/201421,597$80.00$1.7M+22.27%
Boess Carsten
Chief Financial Officer & Senior Vice President
Sale2/17/201516,716$100.74$1.7M+0.02%
Boess Carsten
Chief Financial Officer & Senior Vice President
Sale2/17/201514,750$99.97$1.5M+0.02%
Williams Glen
Senior Vice President-Technical Operations
Buy4/08/201524,600$57.56$1.4M+2.57%
Page of 10

To view my watchlist

Not a member yet?

Sign up now for a free account